SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052242
Filing Date
2020-11-09
Accepted
2020-11-09 08:51:35
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-10q_20200930.htm   iXBRL 10-Q 2168701
2 EX-10.1 vrca-ex101_46.htm EX-10.1 446712
3 EX-31.1 vrca-ex311_9.htm EX-31.1 17025
4 EX-31.2 vrca-ex312_7.htm EX-31.2 16964
5 EX-32.1 vrca-ex321_8.htm EX-32.1 11200
  Complete submission text file 0001564590-20-052242.txt   7826003

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20200930.xsd EX-101.SCH 44863
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20200930_cal.xml EX-101.CAL 49901
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20200930_def.xml EX-101.DEF 142703
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20200930_lab.xml EX-101.LAB 394567
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20200930_pre.xml EX-101.PRE 280464
11 EXTRACTED XBRL INSTANCE DOCUMENT vrca-10q_20200930_htm.xml XML 1323848
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 201296291
SIC: 2834 Pharmaceutical Preparations